Post-Operative Cognitive Dysfunction in Normal Aging Patients Undergoing Elective Orthopedic Surgery
POCD
POCD
Sponsor study identifier
observational
47
1 country
1
Study Start
January 6, 2020
Actual (reported)Primary Completion
May 9, 2023
Actual (reported)Study Completion
June 14, 2023
Actual (reported)Post-operative cognitive dysfunction (POCD) is a common concern for aging patients undergoing elective orthopedic surgery and significantly effects health outcomes. This study aims to evaluate the incidence of and risk factors associated with post-operative cognitive dysfunction in aging patients without prior history for mild cognitive impairment or dementia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 14, 2023
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 6, 2020
Actual (reported)February 11, 2020
Actual (reported)February 12, 2020
Actual (reported)May 9, 2023
Actual (reported)June 14, 2023
Actual (reported)April 19, 2024
Actual (reported)Presence of Post Operative Cognitive Dysfunction (POCD)
Defined as a decline of 1.5 or greater standard deviation on any one of the cognitive test performed from baseline to three-months post surgery. Score range: 0-100. A higher score indicates more cases of incident of POCD.
3 months
Older adults undergoing elective orthopedic surgery.
Patients having knee (unilateral primary osteoarthritis or bilateral primary osteoarthritis) surgery, hip (unilateral primary osteoarthritis or bilateral primary osteoarthritis) or shoulder (primary osteoarthritis) elective surgery.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Patients presenting to Regions Hospital orthopedics center in Saint Paul, MN with a scheduled surgery fitting the diagnostic codes listed in the eligibility criteria.
HealthPartners Neuroscience Center
Saint Paul, Minnesota, 55130, United States
Michael H Rosenbloom, MD
HealthPartners Neurology
47 participants (actual enrollment reported by the registry).
First Submitted
February 11, 2020
First Posted
February 12, 2020
Study Start
January 6, 2020
Actual (reported)Sugammadex and Cognitive Function
Contact the study team to confirm eligibility.
Primary Completion
May 9, 2023
Actual (reported)Study Completion
June 14, 2023
Actual (reported)Last Updated
April 19, 2024
Results First Posted
April 19, 2024
Record last verified: 2022-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: